• Understanding 340B Programs: An Interview with Antonio Ciaccia, CEO, 46brooklyn Research

  • 2024/04/25
  • 再生時間： 47 分
  • ポッドキャスト

Understanding 340B Programs: An Interview with Antonio Ciaccia, CEO, 46brooklyn Research

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In this episode, we explore the 340B Drug Pricing Program, an essential yet complex component of the American drug supply landscape that aims to enable healthcare entities to offer more affordable medication to underserved populations. We interview Antonio Ciaccia, a drug pricing and 340B expert who provides an in-depth look at how the program works, its financial incentives, and how stakeholders have exploited this well-intentioned program, all to the detriment of patients.

    • Antonio Ciaccia, President, 3 Axis Advisors and CEO, 46brooklyn Research, an Ohio non-profit Corporation
    • 46brooklyn
    • Ohio Pharmacist Association
    • 3 Axis Advisors
    • Medicaid
    • 340B Program
    • 340B Litigation
    • 340 Eligibility, HRSA
    • Covered Entities
    • Medicaid Drug Rebate Program
    • Obamacare
    • Indian Health Service
    • "Money from Sick People," Report from 46Brooklyn
    • Medicare
    • Pharmacy Benefit Managers (PBMs)
    • Jamie Robinson, Health Economist

    Medical terminology referenced in this episode:

    • Novolog

    Questions or comments?
    Email us at comments@prescriptionforbetteraccess.com.
    Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

In this episode, we explore the 340B Drug Pricing Program, an essential yet complex component of the American drug supply landscape that aims to enable healthcare entities to offer more affordable medication to underserved populations. We interview Antonio Ciaccia, a drug pricing and 340B expert who provides an in-depth look at how the program works, its financial incentives, and how stakeholders have exploited this well-intentioned program, all to the detriment of patients.

  • Antonio Ciaccia, President, 3 Axis Advisors and CEO, 46brooklyn Research, an Ohio non-profit Corporation
  • 46brooklyn
  • Ohio Pharmacist Association
  • 3 Axis Advisors
  • Medicaid
  • 340B Program
  • 340B Litigation
  • 340 Eligibility, HRSA
  • Covered Entities
  • Medicaid Drug Rebate Program
  • Obamacare
  • Indian Health Service
  • "Money from Sick People," Report from 46Brooklyn
  • Medicare
  • Pharmacy Benefit Managers (PBMs)
  • Jamie Robinson, Health Economist

Medical terminology referenced in this episode:

  • Novolog

Questions or comments?
Email us at comments@prescriptionforbetteraccess.com.
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
身体的病い・疾患 衛生・健康的な生活 生物科学
続きを読む 一部表示

Understanding 340B Programs: An Interview with Antonio Ciaccia, CEO, 46brooklyn Researchに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。